Please visit the Novartis Oncology Pipeline, which includes compounds in all phases of development, starting with preclinical studies through large Phase III randomized trials.
- Contact Information
Novartis Oncology Global Public Relations
- Media Releases
- 08-Dec-2011 New data confirms Novartis drug Afinitor® significantly extends time women with advanced breast cancer live without tumor growth »
- 26-Sep-2011 Novartis drug Afinitor® helps women with advanced breast cancer live significantly longer without their disease progressing »
- 05-Jul-2011 Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer; potential to address significant unmet need »